SCHEMBL7520086

SCHEMBL7520086

O=C1C=C(NS(=O)(=O)c2ccc(Cl)cc2)CO1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 1/20 0.50
MAPT P10636 1/20 0.46
CYP19A1 P11511 1/20 0.45
ALDH1A1 P00352 2/20 0.44
KDM1A O60341 1/20 0.43
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA12 O43570 1/20 0.43
CA3 P07451 1/20 0.43
CA4 P22748 1/20 0.43
CA6 P23280 1/20 0.43
CA5A P35218 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CA13 Q8N1Q1 1/20 0.43
CA14 Q9ULX7 1/20 0.43
CA5B Q9Y2D0 1/20 0.43
MMP1 P03956 1/20 0.43
MMP2 P08253 1/20 0.43
MMP9 P14780 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7520380 0.73 MT-CO2 (0.51) MAPTALDH1A1
SCHEMBL2371816 0.69 CES1 (0.64) CES1CYP19A1ALDH1A1CA1CA2
SCHEMBL6554630 0.68 CES1 (1.00) CES1MAPTCYP19A1ALDH1A1WDR5
SCHEMBL2474197 0.68 CES1 (1.00) CES1MAPTCYP19A1ALDH1A1WDR5
SCHEMBL7516899 0.68 NPC1 (0.51) MAPTALDH1A1CA1CA2CA12
SCHEMBL12353348 0.67 CA2 (0.64) CES1CYP19A1ALDH1A1CA1CA2
SCHEMBL7525086 0.67 NPC1 (0.50) MAPTALDH1A1
SCHEMBL27330468 0.67 CES1 (0.47) CES1CYP19A1ALDH1A1CA1CA2
SCHEMBL2240607 0.66 CA2 (0.61) CES1CYP19A1ALDH1A1CA1CA2
SCHEMBL6926687 0.65 CA2 (0.67) CES1CYP19A1ALDH1A1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1173420-A2 HETEROCYCLIC COMPOUNDS HAVING ANTITUMOR ACTIVITY Novuspharma S.p.A. (IT) 2002-01-23 EP disclosed
WO-2000053581-A2 HETEROCYCLIC COMPOUNDS HAVING ANTITUMOR ACTIVITY NOVUSPHARMA S.P.A. (IT) 2000-09-14 WO disclosed